MOORS & CABOT, INC. – Edwards Lifesciences Corporation Transaction History
MOORS & CABOT, INC. portfolio value:
$4.02M
portfolio value
MOORS & CABOT, INC. quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -3.13% | -1.57K shares | -756K | $82.63 | 48.68K |
Q2 2022 | share | Decrease | -0.12% | -62 shares | -1.14M | $95.09 | 50.25K |
Q1 2022 | share | Decrease | -2.00% | -1.02K shares | -728K | $117.72 | 50.31K |
Q4 2021 | share | Decrease | -3.50% | -1.86K shares | 629K | $130.68 | 51.33K |
Q3 2021 | call | Decrease | -100.00% | -500 shares | -13K | $113.21 | 0 |
Q3 2021 | share | Decrease | -0.60% | -322 shares | 479K | $113.21 | 53.20K |
Q2 2021 | share | Increase | +0.82% | 434 shares | 1.10M | $103.57 | 53.52K |
Q2 2021 | call | 0.00% | 0 shares | 8K | $103.57 | 500 | |
Q1 2021 | share | Decrease | -3.03% | -1.66K shares | -549K | $83.64 | 53.09K |
Q1 2021 | call | Increase | 0.00% | 500 shares | 5K | $83.64 | 500 |
Q4 2020 | share | Decrease | -1.20% | -667 shares | 566K | $91.23 | 54.75K |
Q3 2020 | share | Increase | +0.34% | 186 shares | 614K | $79.82 | 55.41K |
Q2 2020 | share | Decrease | -3.20% | -1.82K shares | 219K | $69.11 | 55.23K |
Q1 2020 | share | Decrease | -7.03% | -4.31K shares | -1.17M | $62.87 | 57.05K |
Q4 2019 | share | Decrease | -3.79% | -2.41K shares | 100K | $77.76 | 61.36K |
Q3 2019 | share | Increase | +3.49% | 2.14K shares | 879K | $73.3 | 63.78K |
Q2 2019 | share | Increase | +2.06% | 1.24K shares | -62K | $61.58 | 61.63K |
Q1 2019 | share | Increase | +2.66% | 1.56K shares | 845K | $63.78 | 60.39K |
Q4 2018 | share | Increase | +11.42% | 6.03K shares | -53K | $51.06 | 58.82K |
Q3 2018 | share | Increase | +9.58% | 4.61K shares | 718K | $58.03 | 52.79K |
Q2 2018 | share | Increase | +1.54% | 729 shares | 134K | $48.52 | 48.18K |
Q1 2018 | share | Decrease | -24.93% | -15.75K shares | -172K | $46.51 | 47.45K |
Q4 2017 | share | Decrease | -0.31% | -198 shares | 69K | $37.57 | 63.21K |
Q3 2017 | share | Decrease | -7.71% | -5.29K shares | -393K | $36.44 | 63.41K |
Q2 2017 | share | Decrease | -2.42% | -1.70K shares | 496K | $39.41 | 68.70K |
Q1 2017 | share | Decrease | -5.63% | -4.2K shares | -117K | $31.36 | 70.41K |
Q4 2016 | share | Decrease | -0.80% | -600 shares | -690K | $31.23 | 74.61K |
Q3 2016 | share | Decrease | -1.18% | -900 shares | 478K | $40.19 | 75.21K |
Q2 2016 | share | Decrease | -2.80% | -2.19K shares | 244K | $33.24 | 76.11K |
Q1 2016 | share | Decrease | -1.45% | -1.15K shares | 184K | $29.4 | 78.30K |